Banka BioLoo Limited (BANKA)
₹70.49 -1.25% last close, 16 Oct
Latest quarterly results (Q1 FY27)
In its latest reported quarter, Q1 FY27, Banka BioLoo's revenue was ₹10.6 Cr (-5.3% year on year, -40.3% on the previous quarter), and net profit ₹-0.0 Cr (against a profit a year earlier); the operating margin was 17.2%.
| Q1 FY27 (₹ Cr) | Value | YoY vs Q1 FY26 | QoQ |
|---|---|---|---|
| Revenue | ₹10.6 | -5.3% | -40.3% |
| Operating profit | ₹1.8 | +434.3% | -45.9% |
| Net profit | ₹-0.0 | to loss | to loss |
| EPS (₹) | -0.01 | to loss | to loss |
| Operating margin | 17.2% | — | — |
BANKA delivery percentage
NSE end-of-day data for
On Fri, 16 Oct 2026, 63.0% of the BANKA shares traded on NSE were taken to delivery, against the stock's own 20-session average of 80.86%. That is lower than usual for this stock. Turnover was only ₹2 lakh, so a handful of trades can move this figure. It closed at a price band (circuit) on 1 session in about the last 20.
Delivery in the last 5 sessions: 99.6% · 80.5% · 91.0% · 91.3% · 63.0%
A description of what the exchange published, not a recommendation. Names such as "accumulation" or "long buildup" label a pattern in the numbers. How delivery is analysed
📢 Recent Corporate Announcements
Banka BioLoo has released the scrutinizer's report and voting results for its 14th Annual General Meeting held on September 17, 2026. All three ordinary resolutions, including the adoption of FY26 financial statements, the re-appointment of director Namita Sanjay Banka, and material related party transactions with subsidiary Megaliter Varunaa Private Limited, were approved with 100% of polled valid votes. For the related party resolution, 7 members holding 60,84,580 shares were excluded as interested parties, leaving 15,811 non-promoter votes which all voted in favor. The company had 4,861 total shareholders as of the record date.
- All 3 resolutions passed with 100% votes in favor across polled shares
- 7 members holding 60,84,580 shares excluded from voting on Resolution 3 due to related-party interests
- Material related party transactions approved with Megaliter Varunaa Private Limited by 15,811 independent votes
- Total shareholder count stood at 4,861 on the record date of September 3, 2025/2026
Banka BioLoo shared its FY26 AGM presentation detailing its business model and financial turnaround. For FY26, total income stood at ₹58.39 crore (+7.1% YoY) with consolidated EBITDA turning positive to ₹6.49 crore and PAT reaching ₹0.39 crore. The company highlighted an unexecuted order book of ₹107 crore (nearly 1.9x FY26 revenue), with ₹70 crore targeted for execution over the next 12 months. Additionally, its asset-holding arm Megaliter reports a lifetime value (LTV) portfolio of over ₹122 crore across 16 contracted projects.
- Unexecuted order book stands at ₹107 crore, with ₹70 crore targeted for the next 12 months
- FY26 total income reached ₹58.39 crore with EBITDA turning positive to ₹6.49 crore vs a loss of ₹2.55 crore in FY25
- Megaliter portfolio lifetime value (LTV) stands at ₹122+ crore across 16 projects (14 operating, 2 WIP)
- Consolidated working capital absorbed ₹6.10 crore in FY26, leaving net operating cash flow at ₹1.05 crore
- Trade receivables and contract assets stood at ₹29.15 crore and ₹9.42 crore respectively as of 31 March 2026
Banka BioLoo Limited held its 14th Annual General Meeting on 17 September 2026 via video conferencing with 34 members present, including 5 promoter group representatives. The agenda included the adoption of FY26 audited standalone and consolidated financial statements, the reappointment of director Mrs. Namita Sanjay Banka, and approval of material related party transactions with subsidiary Megaliter Varunaa Private Limited. Voting results and the Scrutinizer's Report will be submitted within two working days.
- 14th AGM held on 17 September 2026 from 3:00 P.M. to 3:50 P.M. IST
- Total of 34 members attended the meeting via video conferencing, including 5 promoter group members
- Remote e-voting was open from 13 September 2026 (9:00 A.M.) to 16 September 2026 (5:00 P.M.)
- Special business tabled: Approval of Material Related Party Transactions with Megaliter Varunaa Private Limited
Banka BioLoo Limited has issued notice for its 14th Annual General Meeting scheduled to take place on September 17, 2026, via video conferencing. The company has fixed September 10, 2026, as the cut-off date for remote e-voting eligibility. Key agenda items include adopting the FY26 audited standalone and consolidated financial statements, re-appointing Director Namita Sanjay Banka upon retirement by rotation, and seeking approval for material related-party transactions with its unlisted subsidiary, Megaliter Varunaa Private Limited.
- 14th AGM scheduled for September 17, 2026, at 3:00 PM IST via VC/OAVM
- Cut-off date for e-voting eligibility fixed as September 10, 2026
- Special business proposed to approve material related-party transactions with subsidiary Megaliter Varunaa Private Limited
- Ordinary business includes adoption of FY26 financial statements and director re-appointment
Banka BioLoo Limited has announced its 14th Annual General Meeting (AGM) scheduled for Thursday, 17 September 2026 at 3:00 PM via video conferencing. The cut-off date to determine shareholder eligibility for remote e-voting is set as 10 September 2026. Remote e-voting will run from 13 September 2026 (9:00 AM) to 16 September 2026 (5:00 PM). The Register of Members and Share Transfer Books will be closed from 11 September 2026 to 17 September 2026.
- 14th AGM scheduled for 17 September 2026 at 3:00 PM IST via VC/OAVM
- Cut-off date for remote e-voting eligibility fixed as 10 September 2026
- Remote e-voting window opens 13 September 2026 (9:00 AM) and closes 16 September 2026 (5:00 PM)
- Book closure period runs from 11 September 2026 to 17 September 2026 (both days inclusive)
Banka BioLoo Limited has announced timelines for its 14th Annual General Meeting (AGM) scheduled for September 17, 2026, at 3:00 PM via video conferencing. The cut-off date to determine shareholder eligibility for remote e-voting is September 10, 2026. The remote e-voting window will be open from September 13, 2026 (9:00 AM) to September 16, 2026 (5:00 PM). Additionally, the company's register of members and share transfer books will remain closed from September 11 to September 17, 2026.
- 14th AGM scheduled for Thursday, 17 September 2026 at 3:00 PM IST via VC/OAVM
- Cut-off date for remote e-voting eligibility set as Thursday, 10 September 2026
- Remote e-voting open from 13 September 2026 (09:00 AM) to 16 September 2026 (05:00 PM)
- Book closure period from 11 September 2026 to 17 September 2026 (both days inclusive)
Banka BioLoo Limited has dispatched the notice for its 14th Annual General Meeting scheduled for September 17, 2026, via video conferencing. The agenda includes the adoption of FY26 financial statements and the re-appointment of Managing Director Mrs. Namita Sanjay Banka (holding 32,64,409 shares) who retires by rotation. Special business seeks shareholder approval for material related party transactions with unlisted subsidiary Megaliter Varunaa Private Limited. The cut-off date to determine e-voting eligibility is September 10, 2026.
- 14th AGM scheduled for September 17, 2026, at 3:00 PM IST via VC/OAVM.
- Cut-off date fixed as September 10, 2026, to determine voting rights for members.
- Re-appointment of Managing Director Namita Sanjay Banka, holding 32,64,409 equity shares as of March 31, 2026.
- Special resolution proposed to approve material related party transactions with subsidiary Megaliter Varunaa Private Limited.
Banka BioLoo reported a 20.5% YoY revenue growth to ₹16.40 Cr for Q1 FY26-27, with PAT rising 162% to ₹0.37 Cr. The company maintains a strong unexecuted order book of ₹82 Cr, which is approximately 144% of its TTM revenue, providing multi-quarter visibility. Its subsidiary, Megaliter Varunaa, has scaled to a ₹122 Cr Lifetime Value (LTV) across 15 projects, focusing on long-term water infrastructure. Despite the growth, the company remains a micro-cap with thin margins and a high P/E ratio.
- Q1 FY26-27 Revenue grew 20.5% YoY to ₹16.40 Cr compared to ₹13.61 Cr in the previous year
- Unexecuted order book stands at ₹82 Cr, representing ~1.44x the TTM revenue of ₹57 Cr
- Net Profit (PAT) increased by 162.3% YoY to ₹37 Lakhs from ₹14 Lakhs
- Subsidiary Megaliter Varunaa reached a cumulative Net Lifetime Value (LTV) of ₹122 Cr across 15 projects
- Company services 25,000+ railway bio-toilet systems daily across 7 zones and 26 states
Banka BioLoo reported a weak Q1 FY27 with consolidated revenue declining 13.1% YoY to ₹10.71 Cr. The company swung to a marginal net loss of ₹0.04 Cr, compared to a break-even position in the same quarter last year. A significant concern for investors is the ₹7.39 Cr in trade receivables from government bodies like Swachha Andhra Corporation, which are currently under dispute but supported by an interim High Court order. The board also approved the re-appointment of the Managing Director and granted 16,000 ESOPs at face value.
- Consolidated Revenue for Q1 FY27 stood at ₹10.71 Cr, down from ₹12.33 Cr in Q1 FY26.
- Reported a Net Loss of ₹0.04 Cr for the quarter, compared to a marginal profit of ₹0.002 Cr in the year-ago period.
- Trade receivables of ₹7.39 Cr from government bodies remain outstanding, representing approximately 13% of TTM revenue.
- Board approved the re-appointment of Namita Sanjay Banka as Managing Director, subject to shareholder approval at the upcoming AGM.
- Granted 16,000 ESOPs to employees at an exercise price of ₹10 per share, with a 4-year vesting schedule.
Banka BioLoo Limited reported a consolidated net loss of ‹0.14 crore for Q1 FY27, a sharp reversal from the ‹1.60 crore profit in the preceding quarter. Revenue for the quarter stood at ‹10.71 crore, representing a 39% decline sequentially and a 13% drop year-on-year. A significant concern remains ‹7.38 crore in trade receivables from government bodies, which are currently under internal and legal review. The board also approved the grant of 16,000 ESOPs at a face value of ‹10 and the re-appointment of the Managing Director.
- Consolidated revenue fell to ‹10.71 crore in Q1 FY27 from ‹17.67 crore in Q4 FY26.
- Swung to a net loss of ‹0.14 crore versus a profit of ‹1.60 crore in the previous quarter.
- Trade receivables of ‹7.38 crore (approx. 13% of TTM revenue) from government bodies are under dispute/review.
- Granted 16,000 ESOPs to employees at an exercise price of ‹10 per share.
- 14th Annual General Meeting (AGM) scheduled for September 17, 2026.
Banka BioLoo Limited has approved the grant of 16,000 stock options to eligible employees under its 2023 Employee Stock Option Plan. These options are exercisable into equity shares at a face value of ₹10 each, representing a likely discount to market price. The vesting is structured over a four-year period, with 25% of the options vesting annually starting from August 2027. This move is a routine administrative action aimed at employee retention and alignment.
- 16,000 options granted to eligible employees under the Banka BioLoo Limited ESOP 2023
- Exercise price fixed at face value of ₹10 per share
- Vesting schedule spans 4 years with 25% vesting at the end of each 12-month period
- Exercise period allows employees 2 years to convert options after each vesting date
- Scheme is confirmed to be in compliance with SEBI (SBEB & SE) Regulations, 2021
Banka BioLoo reported a weak set of numbers for Q1 FY27, with consolidated revenue falling 12.3% YoY to Rs 10.71 Cr. The company swung to a consolidated net loss of Rs 3.93 Lakhs, a sharp decline from the Rs 1.60 Cr profit recorded in the preceding quarter (March 2026). A significant concern remains the Rs 7.38 Cr in trade receivables from government bodies, which is currently under discussion and represents approximately 21.7% of the company's net worth. The board also approved the re-appointment of Namita Sanjay Banka as Managing Director and granted 16,000 new ESOPs.
- Consolidated revenue for Q1 FY27 stood at Rs 10.71 Cr, down from Rs 12.21 Cr in the same quarter last year.
- Net loss of Rs 3.93 Lakhs reported for the quarter, compared to a profit of Rs 1.60 Cr in Q4 FY26.
- Trade receivables of Rs 7.38 Cr from government bodies (CDMA and Swachha Andhra Corp) remain outstanding.
- Granted 16,000 ESOPs at an exercise price of Rs 10 per share, vesting over a 4-year period.
- Re-appointment of Promoter Namita Sanjay Banka as Managing Director approved, subject to AGM on Sept 17, 2026.
Banka BioLoo Limited has filed its quarterly compliance report under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. The company confirmed that the regulation is not applicable for the quarter ended June 30, 2026. This confirmation is supported by a letter from its Registrar and Share Transfer Agent (RTA), Bigshare Services Private Limited, dated July 4, 2026. This is a standard administrative filing with no impact on business operations.
- Compliance report filed for the quarter ended June 30, 2026
- Regulation 74(5) of SEBI (Depositories and Participants) Regulations declared not applicable
- Confirmation letter received from RTA Bigshare Services Private Limited on July 4, 2026
- Filing submitted to the National Stock Exchange on July 10, 2026
Banka BioLoo Limited has informed the exchange that its trading window will be closed starting July 1, 2026, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. This closure is ahead of the announcement of the company's un-audited financial results for the quarter ending June 30, 2026. The window will remain closed for all designated persons until 48 hours after the results are declared. This is a standard regulatory procedure for listed companies and does not indicate any fundamental change in the business.
- Trading window closure effective from Wednesday, July 1, 2026
- Closure pertains to the un-audited financial results for the quarter ending June 30, 2026
- Window to remain closed until 48 hours after the declaration of financial results
- Restriction applies to all Directors, Designated Persons, and their immediate relatives
Banka BioLoo Limited has successfully completed the redemption of 430 secured, unrated, and unlisted non-convertible debentures (NCDs). The total repayment amount stands at Rs 4.30 crore, with each unit valued at Rs 1,00,000. The company received a No Due Certificate on June 25, 2026, confirming that the facility was fully repaid on June 22, 2026. This debt reduction is expected to lower interest costs and improve the company's overall financial health.
- Redeemed 430 secured, unrated, and unlisted NCDs at par value.
- Total aggregate value of the redemption is Rs 4.30 crore.
- Full repayment confirmed by the Debenture Holder as of June 22, 2026.
- Received official No Due Certificate dated June 24, 2026, confirming zero outstanding debt for this facility.
Financial Performance
Financial analysis data not yet available for this company.
Operational Drivers
Operational analysis data not yet available for this company.
Strategic Growth
Growth Strategy
The company is implementing a human capital retention strategy by granting 86,500 options under the Banka BioLoo Limited Employees Stock Option Plan - 2023. This strategy aims to drive long-term growth by aligning employee interests with shareholder value through a 48-month vesting schedule, where 25% of options vest annually. This ensures the retention of technical expertise required for the execution of sanitation and bio-toilet infrastructure projects.
Products & Services
Bio-toilets (BioLoos), sanitation systems, and waste management solutions.
Brand Portfolio
Banka BioLoo
External Factors
Industry Trends
The sanitation industry is shifting toward sustainable and decentralized waste management. Banka BioLoo is positioning itself as a compliant leader by maintaining ISO 14001-2015 (Environmental Management) and ISO 9001-2015 (Quality Management) certifications, ensuring it meets the evolving regulatory and environmental standards of the green infrastructure sector.
Competitive Moat
The company's moat is built on its specialized ISO 9001, 14001, and 45001 certifications. These certifications are critical for securing high-value government and corporate sanitation tenders, ensuring 100% compliance with international quality and safety standards, which creates a significant barrier for uncertified competitors.
Regulatory & Governance
Environmental Compliance
The company maintains ISO 14001-2015 certification for environmental management systems, though specific ESG compliance costs in INR are not disclosed.
Risk Analysis
Key Uncertainties
The primary uncertainty involves the potential dilution of equity from the 86,500 shares to be issued under the ESOP plan. There is also a risk that if the market price does not significantly exceed the Rs. 10 face value, the retention impact of the 25% annual vesting schedule may be diminished.
